'Merged' Dong-A Pharmaceutical Posts Record Earnings… Power of Drugs and Ointments
Predicted impact: Low
Record Q3 sales of ₩431B, up 12.7%; already reported in recent days.
000640 · KOSPI · ₩000640 · 동아제약
Predicted impact: Low
Record Q3 sales of ₩431B, up 12.7%; already reported in recent days.
Predicted impact: Low
Q3 sales up 12.7% to ₩431B, already reported in prior items.
Predicted impact: Low
Q3 revenue of ₩431B and profit up 5%; modest relative to company size.
Predicted impact: Low
Q3 sales up 12.7% is a modest, already-reported quarterly gain.
Predicted impact: Low
Q3 sales of ₩431B and operating profit of ₩35.1B; small versus the ₩1.5T revenue base and already reported.
Predicted impact: Low
Q3 operating profit up 5.4% is modest, and the Q3 earnings figure was already reported in the last 14 days.
Predicted impact: Low
Q3 operating profit ₩35.1B, up 5%; preliminary earnings were already filed in the last 14 days.
Predicted impact: Low
Predicted impact: Low
Predicted impact: Low
Routine muscle relaxant pack release with no size or financial impact disclosed.
Predicted impact: Low
Predicted impact: Low
Small charity donation of sanitary pads; negligible financial impact.
Predicted impact: Low
Photo of a golf trophy ceremony; no financial news about the company.
Also known as: Dong-A Pharmaceutical / 동아제약 / 000640 / KRX:000640
Source: KRX statistical information